2018
DOI: 10.26538/tjnpr/v2i2.5
|View full text |Cite
|
Sign up to set email alerts
|

Development of Okra-Based Antidiabetic Nutraceutical Formulation from Abelmoschus esculentus (L.) Moench (Ex-maradi Variety)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 17 publications
2
7
0
Order By: Relevance
“…Oxidative stress is one of the hallmarks of diabetes mellitus. Hence, agents that inhibit oxidative reactions could reduce complications caused by diabetes [20]. This study shows that diabetic control rats fed normal diet significantly elevated (p < 0.05) serum SOD activities and MDA levels compared to diabetic rats fed okrabased diet.…”
Section: Discussionmentioning
confidence: 55%
“…Oxidative stress is one of the hallmarks of diabetes mellitus. Hence, agents that inhibit oxidative reactions could reduce complications caused by diabetes [20]. This study shows that diabetic control rats fed normal diet significantly elevated (p < 0.05) serum SOD activities and MDA levels compared to diabetic rats fed okrabased diet.…”
Section: Discussionmentioning
confidence: 55%
“…Several efforts are being made to improve the well-known hypoglycemic outcomes of okra fruit by formulating different proportions of seeds and peels of Ex-maradi Okra fruit in the ratio of (10:90, 20:80, 30:70, 40:60, 50:50%, and so on), which is subsequently followed by investigating the antidiabetic and antioxidant efficacy of these formulations in vitro. Recent findings have led to the conclusion that seeds and peels at the ratio of 10:90% are the most efficient in exhibiting substantial in vitro antidiabetic and antioxidant efficacy [ 134 , 135 ]. Subsequently, it was recommended that the nutraceutical formulation of peel and Ex-maradi okra seeds in the ratio (10:90) exhibits substantial hypoglycemic and hypolipidemic activity in alloxan models of diabetes (rodents) and was thus appropriate for further improvements for the formulation of okra-based nutraceutical interventions in diabetes mellitus [ 135 ].…”
Section: Formulation and Development Of Okra-based Nutraceuticalsmentioning
confidence: 99%
“…Moreover, the current work of Muhammad et al [104] has developed and tested a potential okra-based antidiabetic nutraceutical formulation from Abelmoschus esculentus (L.) Moench (ex-maradi variety): this formulation consists of a 10:90% (seeds:peel) formulation and has shown a reduction effect the rate of glucose adsorption and diffusion and thus can retard increase in postprandial blood glucose level than the other combinations tested in the study (proportions of the powdered seeds and peels samples 80:20%, 70:30%, 60:40%, 50:50%, and vice versa).…”
Section: An Updated Overview Of Potential Beneficial Effects Assocmentioning
confidence: 99%